Page last updated: 2024-11-13

sodium stearyl fumarate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sodium stearyl fumarate: an excipient [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23665634
CHEMBL ID2107515
SCHEMBL ID25396
SCHEMBL ID25393
MeSH IDM0509632

Synonyms (44)

Synonym
sodium monooctadecyl 2-butenedioate, (e)-
sodium stearyl fumarate
sodium octadecyl fumarate
sodium monooctadecyl fumarate
einecs 223-781-1
sodium monostearyl fumarate
2-butenedioic acid (e)-, monoactadecyl ester, sodium salt
pruv
4070-80-8
sodium stearyl fumarate (nf)
D05876
fumaric acid stearyl ester sodium salt
fumaric acid octadecyl ester sodium salt
S0879
CHEMBL2107515
7cv7wjk4ui ,
unii-7cv7wjk4ui
sodium stearyl fumarate [nf]
fumaric acid, monooctadecyl ester, sodium salt
AKOS015899539
STFSJTPVIIDAQX-LTRPLHCISA-M
sodium stearyl fumarate [mart.]
sodium stearyl fumarate [fcc]
sodium stearyl fumarate [ep monograph]
sodium stearyl fumarate [inci]
sodium stearyl fumarate [usp-rs]
sodium stearyl fumarate [vandf]
sodium stearyl fumarate [mi]
fumaric acid, octadecyl ester, sodium salt
sodium stearyl fumarate [ii]
sodium 2-octadecylfumarate
SCHEMBL25396
SCHEMBL25393
mfcd07782099
sodium stearyl fumarate; sodium octadecyl (e)-butenedioate
stearyl fumarate sodium
sodium;(e)-4-octadecoxy-4-oxobut-2-enoate
DTXSID901021880
Q27268090
sodium octadecyl fumarate;sodium 2-octadecylfumarate
A851841
CS-0152200
stearyl fumarate sodium 100 microg/ml in methanol
HY-W099558

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The water absorption rate of the tablets containing talc was much faster than that of the tablets containing other lubricants."( Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol.
Kojima, M; Kuno, Y; Nakagami, H; Terada, K; Yonemochi, E, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
"The characteristics of various pharmaceutical dosage forms are influenced by surface properties such as the friction behavior."( Nanoscopic friction behavior of pharmaceutical materials.
Lee, J, 2007
)
0.34
"The vibrating tube method can be used to evaluate the flowability properties of lubricated powders, and the experimental results provide useful information on the production of pharmaceutical solid dosage forms."( Measurement of flowability of lubricated powders by the vibrating tube method.
Horio, T; Matsusaka, S; Yasuda, M, 2013
)
0.39
"This study investigates the effects of a variety of coating materials on the flowability and dissolution of dry-coated cohesive ibuprofen powders, with the ultimate aim to use these in oral dosage forms."( Influence of coating material on the flowability and dissolution of dry-coated fine ibuprofen powders.
Denman, JA; Hapgood, KP; Morton, DA; Qu, L; Stewart, PJ; Zhou, QT, 2015
)
0.42
"Continuous manufacturing of solid oral dosage forms is promising for increasing the efficiency and quality of pharmaceutical production and products."( Provoking an end-to-end continuous direct compression line with raw materials prone to segregation.
Abrahmsén-Alami, S; Ervasti, T; Folestad, S; Fransson, M; Karttunen, AP; Ketolainen, J; Korhonen, O; Lakio, S; Tajarobi, P; Wikström, H, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (8 Items)

ItemProcessFrequency
Suppoerts Fat Metabolismcore-ingredient1
Vegancore-ingredient1
Non-gmocore-ingredient1
Natural-health-productcore-ingredient1
Npn-80039406core-ingredient1
Products without glutencore-ingredient1
Products for specific dietscore-ingredient1
Specific productscore-ingredient1

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's6 (31.58)29.6817
2010's9 (47.37)24.3611
2020's3 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.50 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index75.08 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]